Canonical Notch signalling is inactive in urothelial carcinoma.
about
Notch3 overexpression enhances progression and chemoresistance of urothelial carcinoma.Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexesCancer stem cells and epithelial-mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approaches.Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer.Perspectives on the discovery of NOTCH2-specific inhibitors.Loss of nuclear NOTCH1, but not its negative regulator NUMB, is an independent predictor of cervical malignancy.
P2860
Canonical Notch signalling is inactive in urothelial carcinoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Canonical Notch signalling is inactive in urothelial carcinoma.
@ast
Canonical Notch signalling is inactive in urothelial carcinoma.
@en
Canonical Notch signalling is inactive in urothelial carcinoma.
@nl
type
label
Canonical Notch signalling is inactive in urothelial carcinoma.
@ast
Canonical Notch signalling is inactive in urothelial carcinoma.
@en
Canonical Notch signalling is inactive in urothelial carcinoma.
@nl
prefLabel
Canonical Notch signalling is inactive in urothelial carcinoma.
@ast
Canonical Notch signalling is inactive in urothelial carcinoma.
@en
Canonical Notch signalling is inactive in urothelial carcinoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
Canonical Notch signalling is inactive in urothelial carcinoma
@en
P2093
Annemarie Greife
Jochen Steinbring
Michèle J Hoffmann
Silvia Jankowiak
P2860
P2888
P356
10.1186/1471-2407-14-628
P407
P577
2014-08-29T00:00:00Z
P5875
P6179
1049246514